Skip to main navigation

Press Releases

Press Releases

Year

Aug 22, 2024

Personalis to Participate at Upcoming Investor Conferences

Aug 19, 2024

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 16, 2024

Personalis and Tempus Announce Expanded Collaboration

Aug 07, 2024

Personalis Reports Second Quarter 2024 Financial Results

Jul 31, 2024

Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Jul 24, 2024

Personalis to Announce Second Quarter 2024 Financial Results

Jul 11, 2024

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

Jun 18, 2024

Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference

Jun 13, 2024

Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call

Jun 04, 2024

ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 26

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website